京新药业(002020) - 2025 Q3 - 季度财报

Financial Performance - Q3 2025 revenue was CNY 1,031,649,329.24, a decrease of 2.57% year-over-year, while year-to-date revenue reached CNY 3,048,192,079.46, down 5.00% compared to the same period last year[5] - Net profit attributable to shareholders for Q3 2025 was CNY 187,732,848.96, an increase of 8.59% year-over-year, with year-to-date net profit at CNY 575,611,846.06, showing a slight increase of 0.10%[5] - Basic and diluted earnings per share for Q3 2025 were both CNY 0.23, reflecting a 15.00% increase compared to the same period last year[5] - Total operating revenue for the current period was ¥3,048,192,079.46, a decrease of 5.01% from ¥3,208,743,897.71 in the previous period[19] - Operating profit for the current period was ¥664,258,601.66, slightly down from ¥671,815,265.63, reflecting a decrease of 1.04%[19] - Net profit before tax was ¥664,916,102.75, compared to ¥676,464,298.28 in the previous period, indicating a decline of 1.61%[19] - The net profit attributable to the parent company shareholders was CNY 575,611,846.06, a slight increase from CNY 575,012,790.33 in the previous period, reflecting a growth of 0.10%[20] - The total comprehensive income attributable to the parent company owners was CNY 575,497,372.10, compared to CNY 575,219,327.84 in the previous period, indicating a growth of 0.05%[20] - The basic and diluted earnings per share increased to CNY 0.70 from CNY 0.67, representing a growth of approximately 4.48%[20] Assets and Liabilities - Total assets at the end of Q3 2025 were CNY 7,978,648,630.10, a decrease of 5.90% from the end of the previous year[5] - Total assets decreased to ¥7,978,648,630.10 from ¥8,479,313,218.60, a reduction of 5.91%[18] - Total liabilities decreased to ¥2,293,129,014.28, down from ¥2,477,769,425.69, a decline of 7.43%[17] - Current assets increased to ¥3,142,880,026.72, up from ¥2,904,776,219.94, an increase of 8.19%[16] - Cash and cash equivalents rose to ¥452,279,163.55, compared to ¥316,266,734.17, reflecting a significant increase of 42.94%[16] - Inventory decreased slightly to ¥783,702,441.62 from ¥792,719,340.04, a decrease of 1.28%[16] - Unappropriated profits increased to ¥3,188,139,806.91 from ¥2,897,381,706.60, an increase of 10.03%[17] Cash Flow - Cash flow from operating activities for the year-to-date period was CNY 615,483,813.37, showing a slight increase of 0.46%[5] - The net cash flow from operating activities was CNY 615,483,813.37, slightly up from CNY 612,693,212.93 in the previous period, showing an increase of 0.46%[23] - Cash inflow from investment activities was CNY 2,038,840,858.84, down from CNY 3,277,371,692.31, a decrease of 37.87%[23] - The net cash flow from investing activities was CNY 514,465,812.65, reflecting a 133.66% increase due to reduced external investments[10] - The net cash flow from financing activities was CNY -981,378,371.85, a significant decrease of 529.57% primarily due to share repurchases[10] - The net cash flow from financing activities was negative CNY 981,378,371.85, worsening from negative CNY 155,879,600.17 in the previous period[23] - The total cash and cash equivalents at the end of the period amounted to CNY 433,628,680.58, an increase from CNY 204,186,009.58 in the previous period[23] - The company received CNY 2,846,292,493.75 in cash from sales of goods and services, a slight increase from CNY 2,838,651,137.39 in the previous period[22] - The company paid CNY 1,020,986,605.26 for goods and services, down from CNY 1,100,794,598.42, indicating a decrease of 7.25%[23] Shareholder Information - The total number of common shareholders at the end of the reporting period is 22,318[11] - The top 10 shareholders hold a total of 60.77% of the shares, with the largest shareholder, Lü Gang, holding 20.77%[11] - The company has repurchased 47,271,295 shares, accounting for 5.49% of the total share capital, with a total transaction amount of 608.72 million RMB[13] - The maximum purchase price for repurchased shares was 14.41 RMB per share, while the minimum was 11.86 RMB per share[13] - The company plans to raise up to 150 million RMB through the fourth employee stock ownership plan, with a purchase price of 12.50 RMB per share[14] - The total number of shares involved in the employee stock ownership plan is 12 million shares[14] - The company has no preferred shareholders or significant changes in the top 10 shareholders due to margin trading[12] - The company’s major shareholder, Lü Gang, and his spouse hold 100% of the shares in Jingxin Holdings Group[11] - The company has not identified any other relationships among the top shareholders that would classify them as acting in concert[12] - The company’s repurchase account does not count towards the top 10 shareholders list[11] Income and Expenses - The company reported a significant increase of 1987.85% in current assets due to an increase in short-term deposits[9] - Investment income for the year-to-date period was CNY 16,687,385.45, a substantial increase of 179.54% year-over-year, attributed to higher dividend income[9] - The company experienced a 53.86% decrease in other income, primarily due to a reduction in government subsidies[9] - Total operating costs decreased to ¥2,417,770,049.29, down 7.33% from ¥2,608,110,283.39[19] - The company reported a decrease in other comprehensive income attributable to the parent company owners, with a net amount of CNY -114,473.96 compared to CNY 206,537.51 in the previous period[20]